A multicenter, double-blind, randomized, active controlled, parallel-group study to evaluate the efficacy, safety, tolerability and pharmacodynamic profiles of TL011 infusions compared with MabThera (rituximab) in subjects with severe, active rheumatoid arthritis treated with methotrexate (MTX)
Phase of Trial: Phase III
Latest Information Update: 04 May 2013
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ALTO
- 23 Jun 2012 Additional trial location (Netherlands) added as reported by European Clinical Trials Database.
- 26 May 2012 Additional locations added as reported by European Clinical Trials Database record.
- 24 May 2012 New trial record